183 related articles for article (PubMed ID: 23123214)
21. Analysis of gene expression in hepatitis B virus transfected cell line induced by interferon.
Xiong W; Wang X; Liu XY; Xiang L; Zheng LJ; Liu JX; Yuan ZH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1053-60. PubMed ID: 14673494
[TBL] [Abstract][Full Text] [Related]
22. Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication.
Tatematsu K; Tanaka Y; Sugiyama M; Sudoh M; Mizokami M
J Med Virol; 2011 Apr; 83(4):587-93. PubMed ID: 21328371
[TBL] [Abstract][Full Text] [Related]
23. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
24. [Affects of HBV genotypes (B/C) on the levels of serum and intrahepatic HBsAg].
Chen JJ; Ma SW; Wang ZH; Sun J; Zhu YF; Hou JL
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1947-51. PubMed ID: 17064586
[TBL] [Abstract][Full Text] [Related]
25. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].
Yao YQ; Zhang DF; Luo Y; Zhang DZ; Huang AL; Wang B; Zhou WP; Ren H; Guo SH
Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138
[TBL] [Abstract][Full Text] [Related]
26. miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes.
Hou ZH; Han QJ; Zhang C; Tian ZG; Zhang J
Liver Int; 2014 Jan; 34(1):58-68. PubMed ID: 23890093
[TBL] [Abstract][Full Text] [Related]
27. [Anti-HBV effect of fusion protein (TA1-IFN) in vitro].
Lu NF; Huang AL; Zheng RQ; Zhu YB; Xia ZF; Tang N; Yan G; Gao XL; Wu Y
Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):252-4. PubMed ID: 15850509
[TBL] [Abstract][Full Text] [Related]
28. [Anti-hepatitis B virus effects of lamivudine and other five drugs in vitro].
Cao H; Tao P
Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(16):1004-7. PubMed ID: 11718074
[TBL] [Abstract][Full Text] [Related]
29. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of adefovir dipivoxil was not related to genotypes B and C of hepatitis B virus: a randomized, double-blind, multicenter clinical study].
Zhao H; Li J; Zhang YX; Chen XY; Wang L; Tang XP; Lei CL; Si CW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):282-4. PubMed ID: 17971947
[TBL] [Abstract][Full Text] [Related]
32. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence.
Wiegand J; Hasenclever D; Tillmann HL
Antivir Ther; 2008; 13(2):211-20. PubMed ID: 18505172
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injection.
Song J; Zhou Y; Li S; Wang B; Zheng X; Wu J; Gibbert K; Dittmer U; Lu M; Yang D
PLoS One; 2014; 9(3):e90977. PubMed ID: 24618716
[TBL] [Abstract][Full Text] [Related]
34. Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly.
Tsai KN; Chong CL; Chou YC; Huang CC; Wang YL; Wang SW; Chen ML; Chen CH; Chang C
J Virol; 2015 Nov; 89(22):11406-19. PubMed ID: 26339052
[TBL] [Abstract][Full Text] [Related]
35. Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection.
Li Y; Luo H; Hu X; Gong J; Tan G; Luo H; Wang R; Pang H; Yu R; Qin B
Pol J Microbiol; 2024 Jun; 73(2):217-235. PubMed ID: 38905278
[TBL] [Abstract][Full Text] [Related]
36. [Study on efficacy and safety of lamivudine and interferon-alpha in treatment of hepatitis B virus transgenic mice with pregnancy].
Li D; Yan YP; Xu DZ; Men K; Zhang JX; Lei XY
Zhonghua Fu Chan Ke Za Zhi; 2005 May; 40(5):315-9. PubMed ID: 15938781
[TBL] [Abstract][Full Text] [Related]
37. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
[TBL] [Abstract][Full Text] [Related]
38. Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice.
Hiraga N; Imamura M; Hatakeyama T; Kitamura S; Mitsui F; Tanaka S; Tsuge M; Takahashi S; Abe H; Maekawa T; Ochi H; Tateno C; Yoshizato K; Wakita T; Chayama K
J Hepatol; 2009 Dec; 51(6):1046-54. PubMed ID: 19853955
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B genotypes and response to antiviral therapy: a review.
Palumbo E
Am J Ther; 2007; 14(3):306-9. PubMed ID: 17515708
[TBL] [Abstract][Full Text] [Related]
40. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion.
Yuen MF; Wong DK; Zheng BJ; Chan CC; Yuen JC; Wong BC; Lai CL
J Viral Hepat; 2007 Apr; 14(4):269-75. PubMed ID: 17381719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
